WHO needs almost €8 million in less than 6 months to stop and contain the spread of monkeypox.

The World Health Organization (WHO) needs 78.2 million euros.Yes (US$87.4 million) for six months, from September 2024 to February 2025, to work with countries, partners and other stakeholders to stop and contain the current monkeypox outbreak (mpox).

WHO will use these funds to implement the critical activities outlined in the Strategic Global Preparedness and Response Plan (SPRP), released this Monday, 26 August 2024. The SPRP is a comprehensive framework developed by WHO to guide the global response to oxovirus pneumonia, with a particular focus on observation, investigation, equitable access to medical countermeasures and community empowerment.

The funds required will be used at WHO headquarters, regional and country offices to support response coordination, technical assistance, operations and deliver medications.

WHO is calling on donors to urgently fund the entire mpox response to prevent further spread and protect those most at risk.

They are asking for help 121 million

Director General of WHO, Tedros Adhanom Ghebreyesus, He said on Monday that the UN agency had developed a plan to stop smallpox outbreaks in Africa, requiring $135 million (almost 121 million euros) in aid.

“Together with our partners, we have developed Global Strategic Preparedness and Response Plan against smallpox, which we shared with all Member States on Friday and which was published today,” Tedros said in the Republic of Congo’s capital, Brazzaville, of the disease formerly known as monkeypox.

“Plan $135 million needed over the next six months to control these outbreaks through integrated surveillance and response,” he stressed at the opening of the 74th session of the WHO Regional Committee for Africa, which runs until this Friday and is attended by health ministers from 47 African countries.

This plan, he clarified, is aimed at minimize zoonotic transmission, empower communities to actively participate in outbreak prevention and control, and promote research and equitable access to medical countermeasures, including vaccines.